Effect of berberine on PPARα-NO signalling pathway in vascular smooth muscle cell proliferation induced by angiotensin IV

Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies

(2015) Angela Pirillo et al.   ATHEROSCLEROSIS

The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges

(2015) Wai San Cheang et al.   BRITISH JOURNAL OF PHARMACOLOGY

Luteolin Inhibits Angiotensin II-Stimulated VSMC Proliferation and Migration through Downregulation of Akt Phosphorylation

(2015) Tongda Xu et al.   Evidence-based Complementary and Alternative Medicine

Smooth Muscle Cell Differentiation: Model Systems, Regulatory Mechanisms, and Vascular Diseases

(2015) Ning Shi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Therapeutic Effects of PPARαon Neuronal Death and Microvascular Impairment

(2015) Elizabeth P. Moran et al.   PPAR Research

Soluble Guanylate Cyclase: A New Therapeutic Target for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

(2015) A Dasgupta et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

PPARα ligand clofibrate ameliorates blood pressure and vascular reactivity in spontaneously hypertensive rats

(2014) Zivar Yousefipour et al.   ACTA PHARMACOLOGICA SINICA

Berberine suppresses in vitro migration of human aortic smooth muscle cells through the inhibitions of MMP-2/9, u-PA, AP-1, and NF-κB

(2014) Su-Jian Liu et al.   BMB Reports

Berberine protects endothelial progenitor cell from damage of TNF-α via the PI3K/AKT/eNOS signaling pathway

(2014) Min Xiao et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Nitric oxide, a protective molecule in the cardiovascular system

(2013) Jing Lei et al.   NITRIC OXIDE-BIOLOGY AND CHEMISTRY

Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials

(2012) Giuseppe Derosa et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

A comparison of the effects of Angiotensin IV on androgen-dependent and androgen-independent prostate cancer cell lines

(2012) Kamila Domińska et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Berberine cooperates with adrenal androgen dehydroepiandrosterone sulfate to attenuate PDGF-induced proliferation of vascular smooth muscle cell A7r5 through Skp2 signaling pathway

(2011) Jia Liu et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Angiotensin IV protects against angiotensin II-induced cardiac injury via AT4 receptor

(2011) Hui Yang et al.   PEPTIDES

Advance of studies on anti-atherosclerosis mechanism of berberine

(2010) Min Wu et al.   Chinese Journal of Integrative Medicine

Red clover extract

(2010) Monika Mueller et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

PPARα activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway

(2009) Yuan-Yuan Ji et al.   BIOCHEMICAL PHARMACOLOGY

PPARs and the Cardiovascular System

(2008) Milton Hamblin et al.   ANTIOXIDANTS & REDOX SIGNALING

The PPARα/p16 INK4a Pathway Inhibits Vascular Smooth Muscle Cell Proliferation by Repressing Cell Cycle–Dependent Telomerase Activation

(2008) Florence Gizard et al.   CIRCULATION RESEARCH

Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells

(2008) Kae-Woei Liang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY